Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
STAT3 Transcription Factor | 3 | 2022 | 872 | 0.990 |
Why?
|
Glucuronidase | 1 | 2024 | 202 | 0.830 |
Why?
|
Gryllidae | 4 | 2024 | 20 | 0.750 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2024 | 698 | 0.680 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2023 | 630 | 0.660 |
Why?
|
Graphite | 3 | 2024 | 77 | 0.660 |
Why?
|
Pericytes | 1 | 2022 | 295 | 0.650 |
Why?
|
Diabetes Mellitus, Experimental | 2 | 2024 | 1116 | 0.620 |
Why?
|
Acute Kidney Injury | 4 | 2022 | 1923 | 0.610 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2024 | 1488 | 0.590 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2022 | 432 | 0.570 |
Why?
|
Kidney | 8 | 2023 | 7033 | 0.550 |
Why?
|
Ear | 1 | 2015 | 172 | 0.490 |
Why?
|
Cicatrix, Hypertrophic | 1 | 2015 | 80 | 0.480 |
Why?
|
Fibrinogen | 3 | 2014 | 888 | 0.430 |
Why?
|
Kidney Diseases | 5 | 2016 | 2092 | 0.420 |
Why?
|
Cyclin-Dependent Kinase 5 | 2 | 2010 | 111 | 0.410 |
Why?
|
Fibrosis | 6 | 2023 | 2052 | 0.390 |
Why?
|
Reperfusion Injury | 3 | 2013 | 1026 | 0.380 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2023 | 2254 | 0.360 |
Why?
|
Receptors, Virus | 1 | 2013 | 642 | 0.340 |
Why?
|
Interleukins | 3 | 2022 | 782 | 0.340 |
Why?
|
Adipocytes | 1 | 2015 | 1190 | 0.310 |
Why?
|
Protein Phosphatase 2 | 1 | 2010 | 231 | 0.310 |
Why?
|
Atherosclerosis | 1 | 2024 | 3407 | 0.300 |
Why?
|
Amide Synthases | 1 | 2007 | 14 | 0.290 |
Why?
|
Cell Adhesion Molecules | 1 | 2013 | 1603 | 0.290 |
Why?
|
Apoptosis | 7 | 2024 | 9478 | 0.280 |
Why?
|
Electrochemistry | 1 | 2007 | 145 | 0.280 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2017 | 2915 | 0.280 |
Why?
|
Alcohol Dehydrogenase | 1 | 2007 | 113 | 0.270 |
Why?
|
Protein Kinases | 1 | 2013 | 1607 | 0.270 |
Why?
|
Autophagy | 2 | 2024 | 1327 | 0.250 |
Why?
|
Heterozygote | 1 | 2012 | 2778 | 0.250 |
Why?
|
MicroRNAs | 4 | 2023 | 3758 | 0.240 |
Why?
|
Nanodiamonds | 1 | 2023 | 2 | 0.230 |
Why?
|
Carboplatin | 4 | 2008 | 793 | 0.230 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2024 | 295 | 0.220 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 2 | 2022 | 826 | 0.220 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2024 | 471 | 0.210 |
Why?
|
Asparagine | 1 | 2023 | 120 | 0.210 |
Why?
|
Membrane Glycoproteins | 1 | 2013 | 3696 | 0.210 |
Why?
|
Stem Cells | 1 | 2015 | 3517 | 0.210 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2024 | 475 | 0.200 |
Why?
|
Bystander Effect | 2 | 2015 | 89 | 0.200 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 2022 | 18 | 0.200 |
Why?
|
Nanoparticles | 2 | 2024 | 1959 | 0.200 |
Why?
|
Smad7 Protein | 2 | 2019 | 39 | 0.200 |
Why?
|
Mice, Inbred C57BL | 10 | 2024 | 22128 | 0.200 |
Why?
|
Mitomycin | 2 | 2015 | 263 | 0.200 |
Why?
|
Cell Cycle | 1 | 2010 | 2926 | 0.200 |
Why?
|
Biosensing Techniques | 1 | 2007 | 647 | 0.180 |
Why?
|
Cell Transdifferentiation | 1 | 2022 | 186 | 0.180 |
Why?
|
Ethanol | 1 | 2007 | 1322 | 0.180 |
Why?
|
Animals | 28 | 2024 | 168089 | 0.180 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2022 | 617 | 0.170 |
Why?
|
Arthritis, Experimental | 1 | 2022 | 291 | 0.170 |
Why?
|
Polycystic Kidney Diseases | 1 | 2020 | 133 | 0.170 |
Why?
|
Mice, Knockout | 6 | 2022 | 14392 | 0.160 |
Why?
|
Mice | 17 | 2024 | 81330 | 0.160 |
Why?
|
MAP Kinase Signaling System | 2 | 2024 | 1480 | 0.160 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 1 | 2020 | 167 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2024 | 2455 | 0.150 |
Why?
|
Aortic Diseases | 1 | 2024 | 735 | 0.150 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2022 | 1331 | 0.150 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2018 | 189 | 0.150 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2024 | 2864 | 0.150 |
Why?
|
Cells, Cultured | 6 | 2024 | 18927 | 0.140 |
Why?
|
Cell Proliferation | 7 | 2024 | 10423 | 0.130 |
Why?
|
Aorta | 1 | 2024 | 2040 | 0.130 |
Why?
|
Drug Design | 2 | 2018 | 1044 | 0.130 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2023 | 1318 | 0.130 |
Why?
|
Mice, Inbred BALB C | 5 | 2021 | 6200 | 0.130 |
Why?
|
Rats, Wistar | 3 | 2018 | 1848 | 0.130 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2016 | 68 | 0.130 |
Why?
|
Autoimmunity | 2 | 2022 | 1356 | 0.120 |
Why?
|
Lupus Nephritis | 1 | 2019 | 317 | 0.120 |
Why?
|
Macrophages | 4 | 2019 | 5755 | 0.120 |
Why?
|
Cell Death | 2 | 2019 | 1676 | 0.120 |
Why?
|
Toxicity Tests | 1 | 2015 | 114 | 0.120 |
Why?
|
DNA Damage | 4 | 2022 | 2443 | 0.120 |
Why?
|
Longevity | 1 | 2022 | 1063 | 0.120 |
Why?
|
Cysts | 1 | 2020 | 680 | 0.120 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1613 | 0.120 |
Why?
|
Cell Survival | 4 | 2019 | 5778 | 0.120 |
Why?
|
Primary Graft Dysfunction | 1 | 2015 | 112 | 0.110 |
Why?
|
Signal Transduction | 5 | 2024 | 23419 | 0.110 |
Why?
|
Diabetic Nephropathies | 1 | 2021 | 973 | 0.110 |
Why?
|
Hedgehog Proteins | 1 | 2018 | 769 | 0.110 |
Why?
|
Environmental Pollutants | 1 | 2023 | 1276 | 0.110 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2022 | 3777 | 0.110 |
Why?
|
Th17 Cells | 2 | 2022 | 794 | 0.110 |
Why?
|
RNA, Messenger | 4 | 2018 | 12747 | 0.110 |
Why?
|
Fatty Acids | 1 | 2021 | 1807 | 0.110 |
Why?
|
Heme Oxygenase-1 | 1 | 2015 | 366 | 0.100 |
Why?
|
RNA, Small Interfering | 4 | 2021 | 3412 | 0.100 |
Why?
|
Inflammation | 3 | 2022 | 10759 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2018 | 2293 | 0.100 |
Why?
|
Phosphorylation | 3 | 2013 | 8300 | 0.100 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 6919 | 0.100 |
Why?
|
Protein Biosynthesis | 2 | 2016 | 2091 | 0.100 |
Why?
|
Fluorouracil | 2 | 2007 | 1642 | 0.100 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2015 | 2019 | 0.090 |
Why?
|
Coordination Complexes | 1 | 2011 | 73 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 2 | 2012 | 2468 | 0.090 |
Why?
|
Intestines | 1 | 2019 | 1908 | 0.090 |
Why?
|
Glucose Transporter Type 4 | 1 | 2010 | 240 | 0.090 |
Why?
|
Bayes Theorem | 1 | 1998 | 2329 | 0.090 |
Why?
|
Pharmaceutical Preparations | 1 | 1998 | 1086 | 0.090 |
Why?
|
Caveolin 1 | 1 | 2011 | 255 | 0.080 |
Why?
|
Monocytes | 1 | 2019 | 2570 | 0.080 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2011 | 425 | 0.080 |
Why?
|
Liver Neoplasms | 2 | 2018 | 4310 | 0.080 |
Why?
|
Protein Binding | 3 | 2022 | 9297 | 0.080 |
Why?
|
Copper | 1 | 2011 | 366 | 0.080 |
Why?
|
Antineoplastic Agents | 5 | 2018 | 13632 | 0.080 |
Why?
|
In Situ Hybridization | 1 | 2012 | 1900 | 0.080 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2022 | 3092 | 0.080 |
Why?
|
DNA Primers | 1 | 2012 | 2814 | 0.070 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2008 | 614 | 0.070 |
Why?
|
Sequence Analysis, RNA | 1 | 2015 | 2011 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2813 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2016 | 1855 | 0.070 |
Why?
|
Blotting, Western | 2 | 2012 | 5032 | 0.070 |
Why?
|
Multiple Sclerosis | 1 | 2022 | 3222 | 0.070 |
Why?
|
Miniaturization | 1 | 2007 | 153 | 0.070 |
Why?
|
Receptor, Insulin | 1 | 2010 | 836 | 0.070 |
Why?
|
Humans | 29 | 2024 | 761222 | 0.070 |
Why?
|
Kidney Tubules, Proximal | 2 | 2021 | 382 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2022 | 3753 | 0.070 |
Why?
|
Adjuvants, Pharmaceutic | 1 | 2006 | 48 | 0.070 |
Why?
|
Electric Conductivity | 1 | 2007 | 405 | 0.070 |
Why?
|
beta-Cyclodextrins | 1 | 2006 | 70 | 0.070 |
Why?
|
Plasmids | 1 | 2011 | 2261 | 0.070 |
Why?
|
Cell Line | 2 | 2023 | 15545 | 0.060 |
Why?
|
Kidney Tubules | 2 | 2019 | 448 | 0.060 |
Why?
|
Base Sequence | 2 | 2015 | 12404 | 0.060 |
Why?
|
Papillomaviridae | 2 | 2011 | 1120 | 0.060 |
Why?
|
Equipment Failure Analysis | 1 | 2007 | 846 | 0.060 |
Why?
|
Rats | 3 | 2018 | 23705 | 0.060 |
Why?
|
Mice, Transgenic | 3 | 2023 | 9520 | 0.050 |
Why?
|
Nerve Tissue Proteins | 1 | 2016 | 4404 | 0.050 |
Why?
|
Antitubercular Agents | 1 | 2012 | 1374 | 0.050 |
Why?
|
Databases, Factual | 1 | 1998 | 7965 | 0.050 |
Why?
|
Larva | 1 | 2024 | 511 | 0.050 |
Why?
|
Tumor Microenvironment | 1 | 2015 | 3875 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2013 | 3114 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2022 | 11512 | 0.050 |
Why?
|
Coumarins | 1 | 2022 | 118 | 0.050 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2022 | 178 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 5773 | 0.050 |
Why?
|
Cell Line, Tumor | 7 | 2018 | 16954 | 0.050 |
Why?
|
Interleukin-17 | 2 | 2021 | 913 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 1 | 2010 | 3726 | 0.050 |
Why?
|
Disease Progression | 3 | 2019 | 13511 | 0.050 |
Why?
|
Caco-2 Cells | 1 | 2022 | 363 | 0.050 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2022 | 183 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5301 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8606 | 0.050 |
Why?
|
Computational Biology | 1 | 2013 | 3499 | 0.050 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinase 2 | 1 | 2021 | 32 | 0.050 |
Why?
|
TNF Receptor-Associated Factor 6 | 1 | 2021 | 61 | 0.050 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2022 | 328 | 0.050 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2022 | 368 | 0.040 |
Why?
|
Palmitic Acid | 1 | 2021 | 149 | 0.040 |
Why?
|
Serum Albumin, Bovine | 1 | 2021 | 319 | 0.040 |
Why?
|
Molecular Conformation | 2 | 2012 | 543 | 0.040 |
Why?
|
Antigens, CD | 1 | 2010 | 4009 | 0.040 |
Why?
|
Kidney Transplantation | 1 | 2015 | 4242 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 11855 | 0.040 |
Why?
|
RNA Interference | 2 | 2021 | 2816 | 0.040 |
Why?
|
Epidermal Growth Factor | 1 | 2022 | 699 | 0.040 |
Why?
|
Neoplasms | 3 | 2018 | 22142 | 0.040 |
Why?
|
TRPP Cation Channels | 1 | 2020 | 177 | 0.040 |
Why?
|
Molecular Dynamics Simulation | 1 | 2022 | 427 | 0.040 |
Why?
|
Single-Cell Analysis | 1 | 2010 | 2452 | 0.040 |
Why?
|
Pyridines | 1 | 2011 | 2872 | 0.040 |
Why?
|
Male | 9 | 2024 | 360703 | 0.040 |
Why?
|
Diethylnitrosamine | 1 | 2018 | 45 | 0.040 |
Why?
|
Equipment Design | 1 | 2007 | 3510 | 0.040 |
Why?
|
Oncogene Protein v-akt | 2 | 2011 | 129 | 0.040 |
Why?
|
Plaque, Amyloid | 1 | 2023 | 762 | 0.040 |
Why?
|
Synovial Membrane | 1 | 2022 | 532 | 0.040 |
Why?
|
Tuberculosis | 1 | 2012 | 2017 | 0.040 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2019 | 153 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2011 | 5103 | 0.040 |
Why?
|
Sulfones | 1 | 2021 | 448 | 0.040 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2018 | 114 | 0.040 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 2018 | 186 | 0.040 |
Why?
|
Structure-Activity Relationship | 1 | 2023 | 3057 | 0.040 |
Why?
|
Th1 Cells | 1 | 2022 | 1042 | 0.030 |
Why?
|
Endocytosis | 1 | 2021 | 950 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2021 | 8531 | 0.030 |
Why?
|
Cilia | 1 | 2020 | 495 | 0.030 |
Why?
|
Leupeptins | 1 | 2015 | 112 | 0.030 |
Why?
|
Macromolecular Substances | 1 | 2018 | 1429 | 0.030 |
Why?
|
HeLa Cells | 2 | 2015 | 3073 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2007 | 3446 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2009 | 714 | 0.030 |
Why?
|
Benzamides | 1 | 2021 | 1371 | 0.030 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 1 | 2015 | 94 | 0.030 |
Why?
|
Carcinoma | 1 | 2006 | 2330 | 0.030 |
Why?
|
Kinetics | 1 | 2023 | 6312 | 0.030 |
Why?
|
Fas Ligand Protein | 1 | 2015 | 216 | 0.030 |
Why?
|
Papillomavirus Infections | 1 | 2007 | 1616 | 0.030 |
Why?
|
Ancrod | 1 | 2014 | 7 | 0.030 |
Why?
|
DNA | 2 | 2023 | 7189 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2023 | 3155 | 0.030 |
Why?
|
Green Fluorescent Proteins | 2 | 2010 | 2062 | 0.030 |
Why?
|
Chemokines | 1 | 2019 | 956 | 0.030 |
Why?
|
In Situ Nick-End Labeling | 1 | 2015 | 613 | 0.030 |
Why?
|
Species Specificity | 1 | 2019 | 2406 | 0.030 |
Why?
|
Microglia | 1 | 2023 | 1358 | 0.030 |
Why?
|
Smad2 Protein | 1 | 2014 | 144 | 0.030 |
Why?
|
beta Catenin | 1 | 2018 | 1042 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 2058 | 0.030 |
Why?
|
DNA Repair | 1 | 2022 | 2041 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2014 | 374 | 0.030 |
Why?
|
Models, Biological | 1 | 2009 | 9458 | 0.030 |
Why?
|
PPAR gamma | 1 | 2015 | 483 | 0.030 |
Why?
|
Colitis | 1 | 2021 | 1234 | 0.030 |
Why?
|
Melanoma | 1 | 2011 | 5694 | 0.030 |
Why?
|
Ureteral Obstruction | 1 | 2014 | 293 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2007 | 5783 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2018 | 1408 | 0.020 |
Why?
|
Enzyme Activation | 2 | 2008 | 3577 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14675 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2023 | 18222 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2022 | 3493 | 0.020 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2011 | 206 | 0.020 |
Why?
|
Trigonella | 1 | 2010 | 3 | 0.020 |
Why?
|
Mitochondria | 1 | 2024 | 3620 | 0.020 |
Why?
|
Cytochalasin B | 1 | 2010 | 74 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2015 | 1822 | 0.020 |
Why?
|
DNA Cleavage | 1 | 2011 | 56 | 0.020 |
Why?
|
Insulin Antagonists | 1 | 2010 | 17 | 0.020 |
Why?
|
Oxygen | 1 | 2022 | 4228 | 0.020 |
Why?
|
Genistein | 1 | 2010 | 86 | 0.020 |
Why?
|
Mice, SCID | 1 | 2015 | 2621 | 0.020 |
Why?
|
Microscopy, Video | 1 | 2010 | 241 | 0.020 |
Why?
|
Doxorubicin | 1 | 2017 | 2224 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2008 | 20982 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2007 | 1404 | 0.020 |
Why?
|
Receptors, Death Domain | 1 | 2009 | 31 | 0.020 |
Why?
|
Tumor Stem Cell Assay | 1 | 2009 | 115 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2023 | 3841 | 0.020 |
Why?
|
Genetic Markers | 1 | 2015 | 2599 | 0.020 |
Why?
|
Edetic Acid | 1 | 2009 | 275 | 0.020 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 2008 | 221 | 0.020 |
Why?
|
Adipokines | 1 | 2011 | 307 | 0.020 |
Why?
|
Androstadienes | 1 | 2010 | 348 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2007 | 20118 | 0.020 |
Why?
|
Cricetulus | 1 | 2010 | 812 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2022 | 4935 | 0.020 |
Why?
|
Obesity | 1 | 2011 | 12940 | 0.020 |
Why?
|
CHO Cells | 1 | 2010 | 1379 | 0.020 |
Why?
|
Melanoma, Experimental | 1 | 2011 | 561 | 0.020 |
Why?
|
Culture Media | 1 | 2009 | 894 | 0.020 |
Why?
|
Plant Extracts | 1 | 2010 | 496 | 0.020 |
Why?
|
Cricetinae | 1 | 2010 | 2412 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2016 | 4243 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2011 | 1978 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2008 | 874 | 0.020 |
Why?
|
Female | 9 | 2018 | 392552 | 0.020 |
Why?
|
Binding Sites | 1 | 2015 | 5988 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2009 | 10756 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2009 | 1334 | 0.020 |
Why?
|
Cell Count | 1 | 2009 | 1831 | 0.020 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2007 | 426 | 0.020 |
Why?
|
Protein Transport | 1 | 2010 | 1958 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2010 | 1967 | 0.010 |
Why?
|
Liver | 1 | 2020 | 7512 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2014 | 3210 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 2635 | 0.010 |
Why?
|
Transfection | 1 | 2011 | 5748 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2015 | 3671 | 0.010 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2007 | 646 | 0.010 |
Why?
|
Ligands | 1 | 2009 | 3264 | 0.010 |
Why?
|
Up-Regulation | 1 | 2011 | 4111 | 0.010 |
Why?
|
Gene Expression | 1 | 2015 | 7571 | 0.010 |
Why?
|
Time Factors | 1 | 2023 | 39957 | 0.010 |
Why?
|
Weight Gain | 1 | 2011 | 2349 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2006 | 1749 | 0.010 |
Why?
|
Cell Membrane | 1 | 2009 | 3661 | 0.010 |
Why?
|
Drug Combinations | 1 | 2006 | 2048 | 0.010 |
Why?
|
Lipids | 1 | 2011 | 3331 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4567 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2011 | 13402 | 0.010 |
Why?
|
Down-Regulation | 1 | 2006 | 2916 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2011 | 17598 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2010 | 3089 | 0.010 |
Why?
|
NF-kappa B | 1 | 2006 | 2475 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 24022 | 0.010 |
Why?
|
Insulin | 1 | 2010 | 6588 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 58952 | 0.010 |
Why?
|
Aged | 2 | 2018 | 169292 | 0.010 |
Why?
|
Middle Aged | 2 | 2018 | 220858 | 0.010 |
Why?
|
Adult | 1 | 2018 | 221120 | 0.000 |
Why?
|